These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 9891705)
1. Ankylosing spondylitis. Clinical features. van der Linden S; van der Heijde D Rheum Dis Clin North Am; 1998 Nov; 24(4):663-76, vii. PubMed ID: 9891705 [TBL] [Abstract][Full Text] [Related]
2. Clinical aspects, outcome assessment, and management of ankylosing spondylitis and postenteric reactive arthritis. van der Linden S; van der Heijde D Curr Opin Rheumatol; 2000 Jul; 12(4):263-8. PubMed ID: 10910177 [TBL] [Abstract][Full Text] [Related]
3. Ankylosing spondylitis and uveitis: overview. Gouveia EB; Elmann D; Morales MS Rev Bras Reumatol; 2012 Oct; 52(5):742-56. PubMed ID: 23090374 [TBL] [Abstract][Full Text] [Related]
5. [HLA B 27 uveitis in ankylosing spondylitis and reactive arthritis]. Dumbrăveanu L; Cuşnir V; Groppa L; Calinina L Oftalmologia; 2010; 54(1):29-35. PubMed ID: 20540366 [TBL] [Abstract][Full Text] [Related]
6. Ankylosing spondylitis. Wolf J; Fasching P Wien Med Wochenschr; 2010 May; 160(9-10):211-4. PubMed ID: 20632147 [TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis. Uygunoğlu U; Uluduz D; Taşçılar K; Saip S Rheumatol Int; 2014 Jan; 34(1):141-3. PubMed ID: 23269571 [TBL] [Abstract][Full Text] [Related]
9. Epidemiologic, clinical, and therapeutic aspects of reactive arthritis and ankylosing spondylitis. Toivanen A; Toivanen P Curr Opin Rheumatol; 1995 Jul; 7(4):279-83. PubMed ID: 7547104 [TBL] [Abstract][Full Text] [Related]
10. Imaging of the seronegative spondyloarthopathies. Amrami KK Radiol Clin North Am; 2012 Jul; 50(4):841-54. PubMed ID: 22643398 [TBL] [Abstract][Full Text] [Related]
11. [Spondyloarthritides]. Rudwaleit M Z Rheumatol; 2017 Dec; 76(10):889-903. PubMed ID: 29043434 [TBL] [Abstract][Full Text] [Related]
12. [Sacroiliitis: the key symptom of spondylathropathies. 1. The clinical aspects]. Bollow M; Braun J; Hamm B Rofo; 1997 Feb; 166(2):95-100. PubMed ID: 9116265 [TBL] [Abstract][Full Text] [Related]
13. [An interview with Alan Ebringer. What is going to happen tomorrow concerning HLA-B27 and ankylosing spondylathritis?. Interview by P. Youinou]. Ebringer A Ann Med Interne (Paris); 1994; 145(4):238-40. PubMed ID: 8092648 [No Abstract] [Full Text] [Related]
15. Clinical aspects of the spondyloarthropathies. Gladman DD Am J Med Sci; 1998 Oct; 316(4):234-8. PubMed ID: 9766484 [TBL] [Abstract][Full Text] [Related]
16. Spinal ankylosing spondylitis: a variant form of ankylosing spondylitis or a distinct disease entity? Gran JT; Husby G; Hordvik M Ann Rheum Dis; 1985 Jun; 44(6):368-71. PubMed ID: 3874605 [TBL] [Abstract][Full Text] [Related]
18. Ankylosing spondylitis in a patient with myelodysplastic syndrome: an association with HLA-B27 or coincidence? Lee J; Kim H; Ahn JK; Hwang JW; Jang JH; Koh EM; Cha HS Rheumatol Int; 2009 Apr; 29(6):689-92. PubMed ID: 18841370 [TBL] [Abstract][Full Text] [Related]
19. Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis. Marcilla M; López de Castro JA Tissue Antigens; 2008 Jun; 71(6):495-506. PubMed ID: 18489433 [TBL] [Abstract][Full Text] [Related]
20. Immunogenetic basis of the seronegative spondyloarthropathies. Ivanyi P Curr Opin Rheumatol; 1992 Aug; 4(4):484-93. PubMed ID: 1503871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]